Locus 29: PEX5L (3q26.33)
| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs9842133 |
carnitine |
T/C |
7349 |
0.66 |
0.006 (0.001) |
4.2·10-12 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs9842133 |
| Chromosomal location | Chr3: 181,146,796 (3q26.33) |
| Gene (distance) | PEX5L (0) |
| Predicted causal gene | unknown |
| Gene/protein classification | - |
| Metabolite (Pathway) | carnitine (Carnitine metabolism; Lipid) |
| Biochemical locus-metabolite relationship | Carnitine is a quaternary ammonium compound required for the transport of fatty acids from the cytosol into the mitochondria during the breakdown of lipids (fats) for the generation of metabolic energy |
| eQTL associations | - |
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | - |
| Drug information |
-
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

